Malignant chapters
About this audiobook · Recording details
Recording vinayak-k-prasad-2020 · Narrated by Vinayak K. Prasad
20 chapters
| Chapter | Title | Start | Duration |
|---|---|---|---|
| 1 | Opening Credits | 0:00:00 | 0:00:18.018 |
| 2 | Introduction | 0:00:18.018 | 0:16:44.959 |
| 3 | Chapter 1: The Basics of Cancer Drugs: Cost, Benefit, Value | 0:17:02.977 | 0:23:23.112 |
| 4 | Chapter 2: Surrogate Endpoints in Cancer: What Are They and Where Are They Used? | 0:40:26.089 | 0:25:43.616 |
| 5 | Chapter 3: The Use and Misuse of Surrogate Endpoints for Drug Approvals | 1:06:09.705 | 0:28:11.457 |
| 6 | Chapter 4: How High Prices Harm Patients and Society | 1:34:21.162 | 0:22:13.452 |
| 7 | Chapter 5: Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine | 1:56:34.614 | 0:20:26.547 |
| 8 | Chapter 6: Financial Conflict of Interest | 2:17:01.161 | 0:23:20.720 |
| 9 | Chapter 7: The Harms of Financial Conflicts and How to Rehabilitate Medicine | 2:40:21.881 | 0:24:30.148 |
| 10 | Chapter 8: Will Precision Oncology Save Us? | 3:04:52.029 | 0:17:38.620 |
| 11 | Chapter 9: Study Design 201 | 3:22:30.649 | 0:38:41.693 |
| 12 | Chapter 10: Principles of Oncology Practice | 4:01:12.342 | 0:26:51.046 |
| 13 | Chapter 11: Important Trials in Oncology | 4:28:03.388 | 0:34:58.619 |
| 14 | Chapter 12: Global Oncology | 5:03:02.007 | 0:26:19.769 |
| 15 | Chapter 13: How Should Cancer Drug Development Proceed? | 5:29:21.776 | 0:33:57.783 |
| 16 | Chapter 14: What Can Three Federal Agencies Do Tomorrow? | 6:03:19.559 | 0:37:09.719 |
| 17 | Chapter 15: What Can People with Cancer Do? | 6:40:29.278 | 0:16:57.196 |
| 18 | Chapter 16: What Can Students, Residents, and Fellows Do? | 6:57:26.474 | 0:13:13.681 |
| 19 | Epilogue: The Hallmarks of Successful Cancer Policy | 7:10:40.155 | 0:13:04.207 |
| 20 | End Credits | 7:23:44.362 | 0:00:14.093 |